Friday, March 13, 2020 11:54:04 AM
We are very pleased that our Roche Diagnostics-developed test to help identify novel coronavirus (SARS-CoV-2) today received an Emergency Use Authorization approval from the FDA and obtained IVD CE-Mark. The cobas SARS-CoV-2 Test is for use on the cobas 6800 and 8800 systems.
Hospitals and laboratories can now run the cobas SARS-CoV-2 Test on Roche’s fully automated cobas 6800 and 8800 systems, which are widely available around the world. These are high volume testing systems that deliver the fastest time-to-results, with the 8800 system able to provide over 4,100 results in 24 hours. This means that more tests can be done faster, bringing certainty to patients, healthcare providers, and communities across the globe.
IF ARYC has a test and it can run hundreds of thousands compared to just the 4,100 tests stated above, wow, that would be huge.
PickleJar Debuts Nationwide Contest With Brian Kelley for Fans to Win a Three-Day Bahama Cruise • NREG • Jun 3, 2024 8:45 AM
ILUS Provides an Update on the Binding Term Sheet Signed with Actelis Networks (NASDAQ: ASNS) • ILUS • May 31, 2024 12:52 PM
Element79 Gold To Provide Summary and Update on Active Exploration Program, Community Relations at RMEC on June 4 • ELEM • May 30, 2024 1:18 PM
Branded Legacy Secures Exclusive Extraction Partnership with One of the World's Largest Kava Distributors and Producers • BLEG • May 30, 2024 8:30 AM
ECGI Holdings, Inc. Announces $2 Million Debt-to-Equity Conversion • ECGI • May 30, 2024 8:30 AM
North Bay Resources Reports Assays up to >25% Mg, 0.1% Ni, 0.1% Cu, 0.01% Co, 0.3 ppm Pt at Tulameen Platinum Project, British Columbia • NBRI • May 29, 2024 9:03 AM